SRNE Projected Dividend Yield
Sorrento Therapeutics Inc ( OTCBB : SRNE )Sorrento Therapeutics, Inc. is a clinical and commercial stage biopharmaceutical company. Co. is engaged in developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune diseases and COVID-19. Co.'s segments include Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate the next-generation of cancer therapeutics. The Scilex segment is organized around its non-opioid pain management operations and clinical pipeline. 21 YEAR PERFORMANCE RESULTS |
SRNE Dividend History Detail SRNE Dividend News SRNE Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |